Pharma | Tags

Biotech & Emerging Modalities

Clinical Trials & Evidence Generation

Data, AI, & Digital Pharma

Drug Discovery & Development

Drug Pricing, Access, & Affordability

Manufacturing & Supply Chain

Regulations & Drug Approval

Therapeutic Areas & Drug Cases

A woman scanning a diabetes continuous glucose monitor on her arm with a phone

We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment

In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”

Caroline Catherman

A shipping container with pills, pill bottles, and money spilling out

What the Iran war could mean for pharmaceuticals

While shortages may not be an immediate concern, drug costs could increase.

A measuring tape wrapping around a large-scaled pill.

How Eli Lilly’s oral GLP-1 could change the obesity drug market

A hot new GLP-1 bombshell has entered the villa.

Caroline Catherman

A medical practitioner looking at MRI results next to a graphic of the nucleus of atoms

Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals

Announcements from both are in line with a federal push for US-produced drugs

Tricia Crimmins

Novo Nordisk will ask for FDA approval on a semaglutide pill for weight loss

Despite FDA crackdown, unapproved GLP-1s still threaten the industry

Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn.

Caroline Catherman

crispr illustration

Could relaxed regulations boost gene therapy for ultra-rare diseases?

Companies like Prime Medicine and Aurora Therapeutics are shooting their shot.

Caroline Catherman

A sign is posted in front of GoodRX headquarters.

GoodRx, Eli Lilly launch direct-to-employer models that reduce reliance on PBMs

Is direct to employer the new direct to consumer?

Caroline Catherman